Jo, S.; Signorile, L.; Kim, S.; Kim, M.-S.; Huertas, O.; Insa, R.; Reig, N.; Shin, D.H.
A Study of Drug Repurposing to Identify SARS-CoV-2 Main Protease (3CLpro) Inhibitors. Int. J. Mol. Sci. 2022, 23, 6468.
https://doi.org/10.3390/ijms23126468
AMA Style
Jo S, Signorile L, Kim S, Kim M-S, Huertas O, Insa R, Reig N, Shin DH.
A Study of Drug Repurposing to Identify SARS-CoV-2 Main Protease (3CLpro) Inhibitors. International Journal of Molecular Sciences. 2022; 23(12):6468.
https://doi.org/10.3390/ijms23126468
Chicago/Turabian Style
Jo, Seri, Luca Signorile, Suwon Kim, Mi-Sun Kim, Oscar Huertas, Raúl Insa, Núria Reig, and Dong Hae Shin.
2022. "A Study of Drug Repurposing to Identify SARS-CoV-2 Main Protease (3CLpro) Inhibitors" International Journal of Molecular Sciences 23, no. 12: 6468.
https://doi.org/10.3390/ijms23126468
APA Style
Jo, S., Signorile, L., Kim, S., Kim, M.-S., Huertas, O., Insa, R., Reig, N., & Shin, D. H.
(2022). A Study of Drug Repurposing to Identify SARS-CoV-2 Main Protease (3CLpro) Inhibitors. International Journal of Molecular Sciences, 23(12), 6468.
https://doi.org/10.3390/ijms23126468